| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lantheus Holdings, Inc. (LNTH) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 43 sells. LNTH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 3.48M | $363.44M | - | |
| ? | 3.48M | $363.44M | - | |
| Other | 332.9K | $34.80M | - | |
| Pres | 108.2K | $11.31M | - | |
| CFO | 88.1K | $9.21M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2017 | Burgstahler David F | Director | Sell | 78,833 | $16.95 | $1,336,384.37 | -5.9% | |
| Sep 5, 2017 | Orlandi Cesare | Chief Medical Officer | Sell | 18,000 | $16.69 | $300,475.80 | -17.1% | |
| Aug 31, 2017 | Burgstahler David F | Director | Sell | 230,685 | $17.25 | $3,979,679.97 | -11.6% | |
| Aug 28, 2017 | Burgstahler David F | Director | Sell | 91,166 | $17.01 | $1,550,884.55 | -4.0% | |
| Aug 16, 2017 | Avista Capital Partners Gp, LLC | 10% Owner | Sell | 140,846 | $17.27 | $2,432,665.45 | -1.3% | |
| Aug 16, 2017 | Burgstahler David F | Director | Sell | 140,846 | $17.27 | $2,432,665.45 | -1.3% | |
| Jul 12, 2017 | Heino Mary Anne50 | President &CEO | Sell | 10,000 | $18.05 | $180,500.00 | -1.7% | |
| Jun 20, 2017 | Avista Capital Partners Gp, LLC | 10% Owner | Sell | 3,000,000 | $14.87 | $44,610,000.00 | -32.3% | |
| Jun 20, 2017 | Burgstahler David F | Director, 10% Owner | Sell | 3,000,000 | $14.87 | $44,610,000.00 | -32.3% | |
| Jun 12, 2017 | Duffy Michael P | See Remarks | Sale+OE | 20,000 | $15.42 | $308,400.00 | -10.6% |